USFDA issues 3 observations for Aurobindo Pharma’s Unit XI
The company has responded to the warning letter and carried out the committed corrections.
The company has responded to the warning letter and carried out the committed corrections.
The two generic drugs have been launched under the brand names Jankey & Sitenali.
The company has reported total income of Rs. 128.79 crores during the period ended June 30, 2022.
The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.
With this acquisition, UBC provides the most comprehensive REMS services and innovative risk mitigation solutions for the biopharmaceutical industry
he company has reported total income of Rs. 5478.62 crores during the period ended June 30, 2022.
Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.
Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex’s existing accomplishments
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
Subscribe To Our Newsletter & Stay Updated